- Home
- BNZI vs FBRX Comparison
BNZI vs FBRX Comparison
Compare BNZI & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- FBRX
- Stock Information
- Founded
- BNZI 2016
- FBRX N/A
- Country
- BNZI United States
- FBRX United States
- Employees
- BNZI N/A
- FBRX N/A
- Industry
- BNZI
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- FBRX Health Care
- Exchange
- BNZI Nasdaq
- FBRX Nasdaq
- Market Cap
- BNZI 9.5M
- FBRX 8.3M
- IPO Year
- BNZI N/A
- FBRX N/A
- Fundamental
- Price
- BNZI $1.71
- FBRX $19.34
- Analyst Decision
- BNZI Strong Buy
- FBRX Strong Buy
- Analyst Count
- BNZI 1
- FBRX 3
- Target Price
- BNZI $125.00
- FBRX $77.58
- AVG Volume (30 Days)
- BNZI 3.3M
- FBRX 140.5K
- Earning Date
- BNZI 11-14-2024
- FBRX 11-14-2024
- Dividend Yield
- BNZI N/A
- FBRX N/A
- EPS Growth
- BNZI N/A
- FBRX N/A
- EPS
- BNZI N/A
- FBRX N/A
- Revenue
- BNZI $4,310,782.00
- FBRX N/A
- Revenue This Year
- BNZI $23.28
- FBRX N/A
- Revenue Next Year
- BNZI $66.99
- FBRX N/A
- P/E Ratio
- BNZI N/A
- FBRX N/A
- Revenue Growth
- BNZI N/A
- FBRX N/A
- 52 Week Low
- BNZI $1.30
- FBRX $4.11
- 52 Week High
- BNZI $194.00
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- BNZI 49.12
- FBRX 54.31
- Support Level
- BNZI $1.34
- FBRX $17.50
- Resistance Level
- BNZI $1.81
- FBRX $20.97
- Average True Range (ATR)
- BNZI 0.23
- FBRX 2.93
- MACD
- BNZI 0.07
- FBRX -1.12
- Stochastic Oscillator
- BNZI 29.68
- FBRX 16.46
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).